Skip to main content

Vertex Pharmaceuticals Europe revenue

  • VRTX · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$538.60−0.74%Close 13 Nov 2026

Europe revenue at Vertex Pharmaceuticals came to $1.0B for the quarter to 30 Sep 2026, up 19.8% from a year earlier.

As Vertex Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$735.3MDec 2023$967.4MMar 2024$806.8MJun 2024$847.7MSep 2024$832.0MDec 2024$826.6MMar 2025$910.9MJun 2025$836.9MSep 2025$885.9MDec 2025$950.0MMar 2026$977.7MJun 2026$1.0BSep 2026
Vertex Pharmaceuticals Europe revenue, every reported period
Period endingEurope revenueChange on a yearFiled
30 Sep 2026$1.0Bup 19.8%3 Nov 2026
30 Jun 2026$977.7Mup 7.3%4 Aug 2026
31 Mar 2026$950.0Mup 14.9%5 May 2026
31 Dec 2025$885.9Mup 6.5%13 Feb 2026
30 Sep 2025$836.9Mdown 1.3%4 Nov 2025
30 Jun 2025$910.9Mup 12.9%5 Aug 2025
31 Mar 2025$826.6Mdown 14.6%6 May 2025
31 Dec 2024$832.0Mup 13.2%13 Feb 2025
30 Sep 2024$847.7Mup 10.6%5 Nov 2024
30 Jun 2024$806.8Mup 0.8%2 Aug 2024
31 Mar 2024$967.4Mup 19.8%7 May 2024
31 Dec 2023$735.3Mup 7.0%15 Feb 2024
30 Sep 2023$766.5Mup 4.9%7 Nov 2023
30 Jun 2023$800.0Mup 22.0%2 Aug 2023
31 Mar 2023$807.2Mup 27.7%2 May 2023
31 Dec 2022$687.2M—10 Feb 2023
30 Sep 2022$730.5Mup 40.8%28 Oct 2022
30 Jun 2022$655.5Mup 42.8%5 Aug 2022
31 Mar 2022$632.3Mup 56.1%6 May 2022
30 Sep 2021$518.8Mup 106.4%3 Nov 2021
30 Jun 2021$458.9Mup 78.1%30 Jul 2021
31 Mar 2021$405.0Mup 57.3%30 Apr 2021
31 Dec 2020$360.0Mup 2.0%11 Feb 2021
30 Sep 2020$251.4Mup 36.0%30 Oct 2020
30 Jun 2020$257.7Mup 43.0%31 Jul 2020
31 Mar 2020$257.4Mup 53.4%1 May 2020
31 Dec 2019$353.0Mup 147.7%13 Feb 2020
30 Sep 2019$184.8Mup 39.1%31 Oct 2019
30 Jun 2019$180.2Mup 32.6%1 Aug 2019
31 Mar 2019$167.8Mup 27.2%1 May 2019
31 Dec 2018$142.5Mup 0.4%13 Feb 2019
30 Sep 2018$132.9Mup 41.3%25 Oct 2018
30 Jun 2018$135.9Mup 47.7%26 Jul 2018
31 Mar 2018$131.9Mup 42.8%27 Apr 2018
31 Dec 2017$141.9M—15 Feb 2018
30 Sep 2017$94.1M—30 Oct 2017
30 Jun 2017$92.0M—28 Jul 2017
31 Mar 2017$92.4M—28 Apr 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Vertex Pharmaceuticals: Product revenues, net revenue · TRIKAFTA/KAFTRIO revenue · ALYFTREK revenue · CASGEVY revenue · JOURNAVX revenue · United States revenue · financial statements

Every KPI and segment of VRTX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.